LRRK2 as a Potential Disease-Modifying Target in Sporadic Parkinson's Disease. Lang AE, Hauser RA, Kalia LV, Hersh B, et al. Mov Disord 2025 Dec 12. doi: 10.1002/mds.70100.

Read + Share

Amedeo Smart

Independent Medical Education

Lang AE, Hauser RA, Kalia LV, Hersh B, et al. LRRK2 as a Potential Disease-Modifying Target in Sporadic Parkinson's Disease. Mov Disord 2025 Dec 12. doi: 10.1002/mds.70100.
PMID: 41388619